IADR Abstract Archives

The Microbiology of Bisphosphonate Associated Osteonecrosis

Objective: Bisphosphonate associated osteonecrosis (BON) associated with the head and neck is a recently emerged side effect of bisphosphonate therapy, used commonly in the management of osteoporosis, multiple myeloma and bone metastasis. Biphosphonates inhibit bone resorption which creates the potential for aseptic necrosis of bone which may subsequently become infected, the mandible in particular appears at heightened risk for BON. There is very little information in the literature concerning the microbiology of BON in the oral cavity. The aim of this study was to determine the type of micro-organisms associated with BON and their antimicrobial susceptibility.

Method: A review of cases with a clinical history of BON was determined by hand searching records submitted to a regional diagnostic oral microbiology laboratory over the last 3 years.

Results: Six specimens (four bone and two swabs) were received from six patients, with a history of either taking or had taken bisphosphonate medication, and had a clinical diagnosis of BON. Fourteen different organisms were isolated from the six specimens. The most common anaerobes isolated were Peptostreptococcus and Veillonella species. The most common facultative isolates were from the Streptococcus mitis group (S. oralis and S. parasanguis) and the Streptococcus anginosus group. One specimen contained a mixed growth of Actinomyces myerii. A large proportion of isolates were resistant to the first line antimicrobials of amoxicillin (74%) and clarithromycin (78%).

Conclusions: Our results, from this small cohort of patients, demonstrate that mixed infections comprising strict anaerobes and Streptococcus spp. are the predominant isolates from BON specimens. Of interest is the reduced antimicrobial susceptibility of these isolates which probably reflects the exposure of this group of patients to multiple courses of antimicrobial therapy. This data should be considered when proposing guidelines for prophylaxis and therapy of BON


Division: British Division Meeting
Meeting: 2009 British Division Meeting (Glasglow, Scotland)
Location: Glasglow, Scotland
Year: 2009
Final Presentation ID: 50
Abstract Category|Abstract Category(s): Scientific Groups
Authors
  • Mcfadzean, Rhona  ( Falkirk and District Royal Infirmary, Falkirk, N/A, United Kingdom )
  • Jackson, M.  ( University of Glasgow Dental School, Glasgow, N/A, United Kingdom )
  • Smith, A.  ( University of Glasgow Dental School, Glasgow, N/A, United Kingdom )
  • Lockhart, Deborah  ( Glasgow Dental Hospital & School, Glasgow, N/A, United Kingdom )
  • Bagg, J.  ( University of Glasgow Dental School, Glasgow, N/A, United Kingdom )
  • SESSION INFORMATION
    Poster Session
    Microbiology & Immunology
    09/02/2009